facturers and brand owners in proportion to the market 
shares of their respective drugs. 
(q) AUTHORIZATION OF APPROPRIATIONS.— 
(1) IN GENERAL.—There is authorized to be 
appropriated to the Environmental Protection Agen-
cy $8,000,000 for fiscal year 2012 and each subse-
quent fiscal year to pay the administrative costs of 
carrying out this section, including the costs of certi-
fying, evaluating, and auditing national pharma-
ceutical stewardship programs under this section. 
(2) SOURCE OF FUNDS.—Amounts authorized 
to be appropriated pursuant to paragraph (1) shall 
be derived exclusively from amounts collected as civil 
penalties under subsection (j) or fees under sub-
section (p). 
SEC. 3. EDUCATION CAMPAIGN ON DRUG DISPOSAL; EVAL-
UATION 
OF 
NATIONAL 
PHARMACEUTICAL 
STEWARDSHIP PROGRAM. 
(a) EDUCATION AND OUTREACH CAMPAIGN.—Not 
later than 18 months after the date of the enactment of 
this Act, the Director of National Drug Control Policy, 
in consultation with the Secretary of Health and Human 
Services and the Administrator of the Environmental Pro-
tection Agency, shall establish and begin implementation 
of an education and outreach campaign— 
VerDate Mar 15 2010 
00:10 Sep 17, 2011
Jkt 099200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H2939.IH
H2939
pwalker on DSK5TPTVN1PROD with BILLS
(1) to increase awareness among members of 
the public regarding how drugs may be lawfully dis-
posed consistent with public safety, public health, 
and environmental protection through national phar-
maceutical stewardship programs under section 2 
and by other appropriate means; and 
(2) to link members of the public to the na-
tional and local educational and outreach activities 
conducted by such programs. 
(b) EVALUATION.— 
(1) IN GENERAL.—Not later than 2 years after 
the date of the enactment of this Act, and annually 
thereafter, the Director of National Drug Control 
Policy, in consultation with the Secretary of Health 
and Human Services and the Administrator of the 
Environmental Protection Agency, shall conduct an 
evaluation of the effectiveness of the national phar-
maceutical stewardship programs under section 2 
and submit a report to the Congress on the results 
of each such evaluation, including recommendations 
for improving the programs. 
(2) METRICS.—The evaluation under paragraph 
(1) shall address each of the following: 
(A) Access to national pharmaceutical 
stewardship programs under section 2. 
VerDate Mar 15 2010 
00:10 Sep 17, 2011
Jkt 099200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H2939.IH
H2939
pwalker on DSK5TPTVN1PROD with BILLS
(B) Awareness of such programs, including 
awareness of the risks of diversion of drugs and 
awareness of the importance of safe storage and 
safe disposal of pharmaceuticals. 
SEC. 4. COMMISSION ON DRUG DISPOSAL AND ITS PUBLIC 
SAFETY, PUBLIC HEALTH, AND ENVIRON-
MENTAL IMPACTS. 
(a) ESTABLISHMENT.—The Administrator of the En-
vironmental Protection Agency shall establish an inter-
agency commission, to be known as the Commission on 
Drug Disposal and its Public Safety, Public Health, and 
Environmental Impacts (in this section referred to as the 
‘‘Commission’’). 
(b) MEMBERSHIP.—The members of the Commission 
shall include the following: 
(1) The Administrator of the Environmental 
Protection Agency. 
(2) The Director of the Centers for Disease 
Control and Prevention. 
(3) The Director of the National Institute of 
Environmental Health Sciences. 
(4) The Administrator of the Drug Enforce-
ment Administration. 
(5) The Commissioner of Food and Drugs. 
(6) The Secretary of Veterans Affairs. 
VerDate Mar 15 2010 
00:10 Sep 17, 2011
Jkt 099200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6201
E:\BILLS\H2939.IH
H2939
pwalker on DSK5TPTVN1PROD with BILLS
(7) The Administrator of the Centers for Medi-
care & Medicaid Services. 
(8) The Director of National Drug Control Pol-
icy. 
(9) Any other Federal official with relevant ex-
pertise appointed or invited to serve on the Commis-
sion by the Administrator of the Environmental Pro-
tection Agency. 
(10) Such individuals with expertise in public 
health, public safety, or the environment as may be 
appointed to serve on the Commission by the Admin-
istrator of the Environmental Protection Agency. 
(11) Such State and local officials and other 
stakeholders as may be invited to serve on the Com-
mission by the Administrator of the Environmental 
Protection Agency. 
(c) DUTIES.—The Commission shall— 
(1) provide a forum for academic, govern-
mental, and other experts, as appropriate, to develop 
a strategy to— 
(A) prevent the entry of drugs into the Na-
tion’s water supply and environment consistent 
with current public safety standards; and 
VerDate Mar 15 2010 
00:10 Sep 17, 2011
Jkt 099200
PO 00000
Frm 00024
Fmt 6652
Sfmt 6201
E:\BILLS\H2939.IH
H2939
pwalker on DSK5TPTVN1PROD with BILLS
(B) protect public health and promote pub-
lic safety by reducing diversion and the risk of 
abuse and accidental overdose; and 
(2) not later than 2 years after the date of the 
enactment of this Act, and annually thereafter, de-
velop and submit to the Congress such a strategy. 
(d) STRATEGY.— 
(1) CONTENTS.—The strategy required by sub-
section (c) shall— 
(A) assess risk hazards and strategies for 
reducing the risks associated with misuse of 
prescription drugs, including diversion, over-
dose, and accidental poisoning; 
(B) address all sources of contamination, 
including development, manufacturing, disposal, 
and metabolic processing; 
(C) include recommendations on minimum 
environmental standards for disposing of drugs 
by incineration and any other means deter-
mined appropriate by the Administrator of the 
Environmental Protection Agency; and 
(D) be designed to inform the regulations 
and guidance of the Environmental Protection 
Agency. 
VerDate Mar 15 2010 
00:10 Sep 17, 2011
Jkt 099200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6201
E:\BILLS\H2939.IH
H2939
pwalker on DSK5TPTVN1PROD with BILLS
(2) CONSIDERATION.—In preparing the strat-
egy required by subsection (c), the Commission shall 
take into consideration the analysis and rec-
ommendations in the report under section 5. 
(e) TERMINATION.—The Commission shall terminate 
on the date that is 5 years after the date of the enactment 
of this Act. 
SEC. 5. REPORT ON DRUG BYPRODUCTS IN THE NATION’S 
WATER SUPPLY. 
(a) IN GENERAL.—Not later than 1 year after the 
date of the enactment of this Act, the Comptroller General 
of the United States shall submit a report to the Congress 
on drugs and drug byproducts in surface and ground 
water in the United States. 
(b) CONTENTS.—At a minimum, the report under 
subsection (a) shall include— 
(1) an analysis of— 
(A) the quantity and distribution of drugs 
and drug byproducts in surface and ground 
water in the United States; 
(B) the risks for humans and the environ-
ment associated with the presence of drugs and 
drug byproducts in such water; and 
VerDate Mar 15 2010 
00:10 Sep 17, 2011
Jkt 099200
PO 00000
Frm 00026
Fmt 6652
Sfmt 6201
E:\BILLS\H2939.IH
H2939
pwalker on DSK5TPTVN1PROD with BILLS
(C) the current efforts of Government 
agencies to prevent the entry of drugs and drug 
byproducts into the water supply; 
(2) recommendations for actions by the Govern-
ment in order to prevent the entry of drugs and 
drug byproducts into the ground and surface waters 
of the United States; and 
(3) recommendations for additional research on 
drugs and drug byproducts in surface and ground 
water in the United States, including a budget for 
such research. 
Æ 
VerDate Mar 15 2010 
00:10 Sep 17, 2011
Jkt 099200
PO 00000
Frm 00027
Fmt 6652
Sfmt 6301
E:\BILLS\H2939.IH
H2939
pwalker on DSK5TPTVN1PROD with BILLS